Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07119463 | Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery(GOAI) | recruiting | Phase 2 | 112 | The First Hospital of Jilin UniversityOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT06298916 | 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer(PHANTOM) | recruiting | Phase 1 / Phase 2 | 26 | Lantheus Medical ImagingINDUSTRY | 1 | Aug 12, 2025 |
| clinicaltrials |
| NCT02491840 | Biomoleculars Markers of Sensitivity to Pre- and Post-operative Chemotherapy of Gastric and Cardia Adenocarcinomas: a Pilot Study | recruiting | N/A | 80 | University Hospital, Strasbourg, FranceOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT07108855 | Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal Dissection(BRIGHT) | recruiting | Phase 1 / Phase 2 | 10 | University Medical Center GroningenOTHER | 1 | Aug 7, 2025 | clinicaltrials |
| NCT07098026 | Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric Cancer | recruiting | N/A | 286 | Hunan Cancer HospitalOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT06732856 | A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer(NEO-CLAUD) | recruiting | Phase 1 / Phase 2 | 57 | Asan Medical CenterOTHER | 1 | Jul 28, 2025 | clinicaltrials |
| NCT06105515 | Laparoscopic and Endoscopic Collaborative Surgery as Rescue-treatment for Advanced Gastric Cancer(LE-RACUS) | recruiting | N/A | 20 | Region StockholmOTHER_GOV | 1 | Jul 22, 2025 | clinicaltrials |
| NCT07076979 | Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC | recruiting | — | 250 | Shanghai Minimally Invasive Surgery CenterOTHER | 1 | Jul 22, 2025 | clinicaltrials |
| NCT06793917 | Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma | recruiting | Phase 3 | 269 | Fujian Cancer HospitalOTHER_GOV | 1 | Jul 20, 2025 | clinicaltrials |
| NCT07069842 | The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment | recruiting | — | 170 | Changzhi People's Hospital Affiliated to Changzhi Medical CollegeOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT07067983 | Clinical Evaluation of GRAPE Model for Gastric Cancer Screening | recruiting | — | 1,000,000 | Zhejiang Cancer HospitalOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT04592211 | Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer | recruiting | Phase 1 / Phase 2 | 71 | Yonsei UniversityOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT05894824 | T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | recruiting | Phase 1 / Phase 2 | 58 | Yonsei UniversityOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT06949033 | Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma | recruiting | Phase 3 | 668 | Zuoyi JiaoOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY Study(ABILITY-1) | recruiting | Phase 1 / Phase 2 | 115 | Medicenna Therapeutics, Inc.INDUSTRY | 7 | Jul 9, 2025 | clinicaltrials |
| NCT06848400 | Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios | recruiting | N/A | 482 | Nanfang Hospital, Southern Medical UniversityOTHER | 3 | Jul 9, 2025 | clinicaltrials |
| NCT07056010 | Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy | recruiting | N/A | 30 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07032961 | A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening | recruiting | — | 10,000 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT04958720 | Spanish Registry of Esophagogastric Cancer(AGAMENON) | recruiting | — | 10,000 | Fundación Sociedad Española de Oncologia MédicaOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT03093688 | Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor | recruiting | Phase 1 / Phase 2 | 40 | Shanghai Public Health Clinical CenterOTHER_GOV | 1 | Jul 2, 2025 | clinicaltrials |
| NCT06895447 | Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy | recruiting | Phase 2 | 40 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03175224 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors(SPARTA) | recruiting | Phase 2 | 497 | Apollomics Inc.INDUSTRY | 11 | Jun 27, 2025 | clinicaltrials |
| NCT07035587 | Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques | recruiting | — | 1,200 | Yonsei UniversityOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT06769425 | HS-10502 Combination Treatment in Patients With Advanced Solid Tumors(HS-10502) | recruiting | Phase 1 | 157 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 24, 2025 | clinicaltrials |
| NCT07034742 | Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer | recruiting | Early Phase 1 | 136 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT07026240 | Post-operative Monitoring of Gastric Cancer | recruiting | — | 258 | Suzhou Huhu Health & Technology Inc.INDUSTRY | 1 | Jun 18, 2025 | clinicaltrials |
| NCT06639490 | Efficacy of RUS GA Surgical Navigation for Robot-assisted Distal Gastrectomy in Gastric Cancer Patients | recruiting | N/A | 330 | Yonsei UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT06766305 | QL1706 Combined With SOX Used in Theperioperative Treatment | recruiting | Phase 1 / Phase 2 | 54 | Xiangdong ChengOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT06346093 | Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer | recruiting | N/A | 124 | Changhai HospitalOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT05944237 | HTL0039732 in Participants With Advanced Solid Tumours | recruiting | Phase 1 / Phase 2 | 150 | Cancer Research UKOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT06791538 | Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer | recruiting | N/A | 740 | Southwest Hospital, ChinaOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT06232395 | Early Detection and Post-operative Monitoring of Gastric Cancer | recruiting | — | 1,197 | Suzhou Huhu Health & Technology Inc.INDUSTRY | 1 | Jun 6, 2025 | clinicaltrials |
| NCT06078930 | Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms | recruiting | — | 100,000 | Zhejiang Cancer HospitalOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT07003334 | Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer(PDICI) | recruiting | — | 268 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT07001592 | Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors(RIOT3) | recruiting | Phase 1 | 18 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)OTHER | 1 | Jun 3, 2025 | clinicaltrials |
| NCT05450835 | OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method(OGT) | recruiting | N/A | 344 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT04850729 | Relationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer. | recruiting | — | 169 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT06157996 | Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore | recruiting | Phase 2 | 92 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT05892289 | Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer | recruiting | N/A | 42 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT05854368 | Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer(PREGASIGN#1) | recruiting | N/A | 2,500 | Institut PasteurINDUSTRY | 1 | May 16, 2025 | clinicaltrials |
| NCT06668454 | Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)(TORO) | recruiting | N/A | 72 | University Health Network, TorontoOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT06784765 | Preventive Use of PIPAC in Locally Advanced Gastric Cancer. | recruiting | N/A | 160 | National Research Oncology and Transplantology Center, KazakhstanOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT06945718 | Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Extended Lymphadenectomy Beyond D2 for Locally Advanced Gastric Cancer (FUGES-30) | recruiting | — | 760 | Fujian Medical UniversityOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT06962293 | Magnetic Guided Counetrtraction During Endoscopic Submucosal Dissection | recruiting | N/A | 20 | Chinese University of Hong KongOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT06742411 | XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC | recruiting | Phase 1 / Phase 2 | 57 | West China HospitalOTHER | 1 | May 7, 2025 | clinicaltrials |
| NCT06028737 | Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer(OCTASUR) | recruiting | Phase 2 / Phase 3 | 150 | Ukrainian Society of Clinical OncologyOTHER | 2 | May 6, 2025 | clinicaltrials |
| NCT02047994 | Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality(GISTAR) | recruiting | Phase 4 | 30,000 | International Agency for Research on CancerOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT06300879 | A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique | recruiting | N/A | 30 | Huashan HospitalOTHER | 1 | May 2, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Aug 13, 2025source: clinicaltrials